Thursday, April 25, 2024 1:40:07 PM
Just My Opinion. I might be biased because i own shares either long or short and/which which i might sell at any time. Do your own dd, my opinion is for entertainment purposes only and not to be construed as investment advice.
Recent GANX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 09:07:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 09:02:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/21/2024 09:22:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/08/2024 08:30:26 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 09/19/2024 10:15:40 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/06/2024 09:01:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 09:00:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:05:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:03:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 09:24:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 09:18:46 PM
- Gain Therapeutics to Hold a Business Update Conference Call on July 1, 2024 • GlobeNewswire Inc. • 06/28/2024 08:39:04 PM
- Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO • GlobeNewswire Inc. • 06/27/2024 08:08:08 PM
- Gain Therapeutics Presents GT-02287 Data at Federation of European Neuroscience Societies (FENS) Forum 2024 Demonstrating Improvements in Cognitive Performance in a Preclinical Model of GBA1 Parkinson’s disease • GlobeNewswire Inc. • 06/27/2024 12:35:48 PM
- Gain Therapeutics to Participate at H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference • GlobeNewswire Inc. • 06/25/2024 11:00:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/17/2024 12:30:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:40:23 PM
- Gain Therapeutics Announces Pricing of $11.0 Million Public Offering • GlobeNewswire Inc. • 06/14/2024 01:00:59 AM
- Gain Therapeutics Announces Proposed Public Offering • GlobeNewswire Inc. • 06/13/2024 08:44:54 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/13/2024 08:38:54 PM
- Gain Therapeutics Announces Acceptance of Late-Breaking Abstract for Poster Presentation at Federation of European Neuroscience Societies (FENS) Forum 2024 • GlobeNewswire Inc. • 05/30/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:06:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:03:12 PM
- Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
- Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for GBA1 Parkinson’s Disease • GlobeNewswire Inc. • 04/24/2024 01:25:00 PM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM